Similarly, targeting FAK in a subset of FSP‐positive CAFs―which would also suppress mechanotransduction‐mediated myofibroblast activation― likewise resulted in more aggressive PDAC tumours, accompanied by enhanced inflammatory chemokine signalling and a switch in tumour metabolism towards malignant cell glycolysis [58]. This evidence concerns the gene PTK2 and neoplasm.